Pancreatic Cancer Genetics

Pancreatology

Volumn 1, Issue 6, 2001, Pages 571-575

  Efthimiou, E ^a   Crnogorac Jurcevic, T ^a   Lemoine, N R ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Cancer genes; Inherited predisposition; Pancreatic cancer

Indexed keywords

GENETIC PREDISPOSITION; GENETICS; HUMAN; PANCREAS TUMOR; REVIEW;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; PANCREATIC NEOPLASMS;

EID: 0035553042     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000055865     Document Type: Article

References (40)

1. Fearon ER: Human cancer syndromes: Clues to the origin and nature of cancer. Science 1997;278:1043-1050.
2. Shields PG, Harris CC: Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 2000;18: 2309-2315.
3. Schnall SF, Macdonald JS: Chemotherapy of adenocarcinoma of the pancreas. Semin Oncol I996;23:220-228.
4. Ghadirian P, Boyle P, Simard A, Baillargeon J, Maisonneuve P, Perret C: Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol 1991;10:183-196.
5. Fernandez E, La Vecchia C, D'Avanzo B, Negri E, Franceschi S: Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 1994;3: 209-212.
6. Silverman DT, Schiffman M, Everhart J, Goldstein A, Lillemoe KD, Swanson GM, et al: Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999;80:1830-1837.
7. Hruban RH, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ, Falatko F, et al: Familial pancreatic cancer. Ann Oncol 1999; 10(suppl 4):69-73.
8. Danes BS, Lynch HAT: A familial aggregation of pancreatic cancer: An in vitro study. JAMA 1982;247:2798-2802.
9. Ehrenthal D, Haeger L, Griffin T, Compton C: Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature. Cancer 1987;59:1661-1664.
10. Evans JP, Burke W, Chen R, Bennett RL, Schmidt RA, Dellinger EP, et al: Familial pancreatic adenocarcinoma: Association with diabetes and early molecular diagnosis. J Med Genet 1995;32:330-335.
11. Lynch HT, Fitzsimmons ML, Smyrk TC, Lanspa SJ, Watson P, McClellan J, et al: Familial pancreatic cancer: Clinicopathologic study of 18 nuclear families. Am J Gastroenterol 1990; 85:54-60.
12. Lynch HT, Fusaro L, Lynch JF: Familial pancreatic cancer: A family study. Pancreas 1992; 7:511-515.
13. Whelan AJ, Bartsch D, Goodfellow PJ: Brief report: A familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med 1995;333:975-977.
14. Levin B: An overview of preventive strategies for pancreatic cancer. Ann Oncol 1999; 10(suppl 4):193-196.
15. Lynch HT, Smyrk T, Kern SE, Hruban RH, Lightdale CJ, Lemon SJ, et al: Familial pancreatic cancer: A review. Semin Oncol 1996;23: 251-275.
16. Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB: Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 1999;131:247-255.
17. Brentnall TA: Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am 2000;84:707-718.
18. Roa BB, Boyd AA, Volcik K, Richards CS: Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 1996;14:185-187.
19. Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, et al: Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 1996;2: 1179-1183.
20. Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, et al: A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996;13:117-119.
21. Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, et al: Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet 1996;13:120-122.
22. Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, et al: Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 1996;56:5360-5364.
23. Ozcelik H, Schmocker B, Di Nicola N, Shi XH, Langer B, Moore M, et al: Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet 1997;16:17-18.
24. Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod SA, et al: Inherited predisposition to pancreatic adenocarcinoma: Role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 2000;60:409-416.
25. Lynch HT, Fusaro RM, Kimberling WJ, Lynch JF, Danes BS: Familial atypical multiple molemelanoma (FAMMM) syndrome: Segregation analysis. J Med Genet 1983;20:342-344.
26. Bergman W, Watson P, de Jong J, Lynch HT, Fusaro RM: Systemic cancer and the FAMMM syndrome. Br J Cancer 1990;61:932-936.
27. Goldstein AM, Fraser MC, Struewing JP, Hussussian CJ, Ranade K, Zametkin DP, et al: Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med 1995;333:970-974.
28. Lal G, Liu L, Hogg D, Lassam NJ, Redston MS, Gallinger S: Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations. Genes Chromosomes Cancer 2000;27:358-361.
29. Borg A, Sandberg T, Nilsson K, Johannsson O, Klinker M, Masback A, et al: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2000; 92:1260-1266.
30. Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA: Genotype-phenotype relationships in US melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst 2000;92:1006-1010.
31. Goggins M, Offerhaus GJ, Hilgers W, Griffin CA, Shekher M, Tang D, et al: Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology: Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 1998; 152:1501-1507.
32. Hemminki A, Tomlinson I, Markie D, Jarvinen H, Sistonen P, Bjorkqvist AM, et al: Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 1997;15:87-90.
33. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, et al: A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998;391:184-187.
34. Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, et al: Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998;18:38-43.
35. Hizawa K, Iida M, Matsumoto T, Kohrogi N, Kinoshita H, Yao T, et al: Cancer in Peutz-Jeghers syndrome. Cancer 1993;72:2777-2781.
36. Giardiello FM, Welsh SB, Hamilton SR, Offerhaus GJ, Gittelsohn AM, Booker SV, et al: Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987;316:1511-1514.
37. Boardman LA, Thibodeau SN, Schaid DJ, Lindor NM, McDonnell SK, Burgart LJ, et al: Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 1998;128:896-899.
38. Su GH, Hruban RH, Bansal RK, Bova GS, Tang DJ, Shekher MC, et al: Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 1999;154:1835-1840.
39. Lowenfels AB, Maisonneuve P, DiMagno EP, Elitsur Y, Gates LK Jr, Perrault J, et al: Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997;89:442-446.
40. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, et al: Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993;328:1433-1437.